Canbud Distribution Corp. (CSE: CBDX) (FSX: CD0) (“Canbud” or the “Company”) is pleased to announce the launch of Empathy Plant Co.™

The trademark has been secured with the CIPO,and positioning for North American harmonization has commenced. Empathy Plant Co. is a plant-based protein brand with 100% compostable packaging to support the company’s sustainability vision.


CANBUD has entered the plant-based protein market via the Empathy Plant Co. brand with 5 SKUs already assembled and a rich developmental pipeline. This offering will be the only certified 100% compostable packaging plant-based wellness brand on the market. Furthermore, the products are naturally sweetened, zero sugar added, non-GMO project verified, gluten-free, soy-free, and available in multiple flavours, positioning this brand amongst industry leaders Vega, Sunwarrior, and Garden of Life.

CANBUD’s VP of Marketing, Adrian Burke offers his thoughts: “With the introduction of the Empathy Plant Company we will be the first (and only) certified 100% compostable plant-based wellness brand. We believe product packaging cannot be a part of the problem. Unless we take a stand on the use of plastic, packaging norms will continue to exist and as a steward of the Earth, we cannot allow this to happen. Our next step is to then change the tone of the conversation. Traditionally the plant-based dialogue has been one of extreme divisiveness; meat eater versus vegan. If we are to shift the needle, we believe more empathetic conversations need to be had. We need to understand each others’ points of view and not instil shame or fear. Only when this conversation moves forward will we be able to align our sustainability goals with cultural opinions. Inclusion is our tone…and an empathetic mindset will help drive the results we would like to see. Ultimately that’s having more people incorporate plant-based offerings into their diets.”

According to Emergen Research: Plant-Based Protein Market to Be Worth USD 16.63 Billion By 2027.

The increasing adoption of organic food in the food & beverage industry and a growing preference for vegetarian diets are driving the demand for the plant-based protein market.

With Empathy Plant Co. at an advanced stage of product development, it is positioning for a strong Direct to Consumer (DTC) offering and aggressively scaling strategically through specialty, food, drug, and mass channels. You can follow all the developments of Empathy Plant Co. via Instagram.com/empathyplantco

Options grant

The Company has granted 300,000 incentive stock options to a consultant of the Company. The options have an exercise price of 22 cents, and a term of 4 years expiring on January 20, 2025.

About Canbud Distribution Corp.

Canbud Distribution Corp. is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals.

For further information, please contact:

ir@canbudcorp.com
or
Robert Tjandra, President and COO
Tel: 1 416 847 7312

Notice Regarding Forward-Looking Information

Certain information set forth in this news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties. This forward-looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Corporation, including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward looking information. The Corporation undertakes no obligation to update forward-looking information except as otherwise may be required by applicable securities law.

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/72673

News Provided by Newsfile via QuoteMedia

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less